Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Shares of NetApp, Inc. (NASDAQ:NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance.

NetApp posted adjusted earnings of $1.94 per share, beating market estimates of $1.69 per share. The company’s quarterly sales came in at $1.610 billion, versus expectations of $1.591 billion, according to data from Benzinga Pro.

NetApp shares jumped 17.3% to $104.50 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

• Nxu, Inc. (NASDAQ:NXU) gained 111.4% to $1.69 in pre-market trading after the company announced it successfully charged a Tesla Cybertruck on Feb. 26.
• Minim, Inc. (NASDAQ:MINM) shares rose 36.4% to $5.87 in pre-market trading. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock.
• Know Labs, Inc. (NYSE:KNW) gained 35.4% to $1.06 in pre-market trading after the company secured U.S. $12 million funding for company's further execution on its clinical research and development initiatives.
• Akanda Corp. (NASDAQ:AKAN) shares surged 30.1% to $0.3273 in pre-market trading. Akanda signed a definitive Share Purchase Agreement and Escrow Agreement for the sale of Portuguese assets to Somai Pharmaceuticals.
• Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) gained 23.4% to $20.62 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.
• Dell Technologies Inc. (NYSE:DELL) rose 21.4% to $115.00 in pre-market trading reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%.
• Cardiff Oncology, Inc. (NASDAQ:CRDF) shares rose 21.3% to $2.14 in pre-market trading after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.
• Navitas Semiconductor Corporation (NASDAQ:NVTS) climbed 14.3% to $7.02 in pre-market trading following upbeat fourth-quarter results.
• Nutex Health Inc. (NASDAQ:NUTX) shares gained 13.3% to $0.1280 in pre-market trading.

Losers

• GigCapital5, Inc. (NASDAQ:GIA) shares dipped 64% to $3.99 in pre-market trading. GigCapital5 announced closing date of March 4, 2024 for business combination with QT Imaging.
• Fisker Inc. (NYSE:FSR) shares tumbled 38.4% to $0.4482 after the company reported preliminary fourth-quarter total revenue results below estimates and said it expects to conclude there is substantial doubt about its ability to continue as a going concern when its annual financial statements are filed with the SEC.
• Sidus Space, Inc. (NASDAQ:SIDU) fell 33.7% to $5.95 in pre-market trading. Sidus Space priced public offering 1,321,000 Class A common share at $6 per share.
• Scilex Holding Company (NASDAQ:SCLX) shares declined 32.2% to $1.54 in pre-market trading after reporting a $10 million bought deal offering.
• New York Community Bancorp, Inc. (NASDAQ:NYCB) fell 28% to $3.45 in pre-market trading after the company identified material weakness in internal controls and announced a leadership transition.
• Gritstone bio, Inc. (NASDAQ:GRTS) fell 26.1% to $2.07 pre-market trading after the company announced an approximately 40% reduction of its workforce.
• Humacyte, Inc. (NASDAQ:HUMA) shares dipped 23.5% to $3.33 in pre-market trading. Humacyte priced its $40.2 million public offering of 13.4 million common stock at $3 per share.
• SoundHound AI, Inc. (NASDAQ:SOUN) shares fell 18.8% to $6.02 in pre-market trading after the company reported weaker-than-expected fourth-quarter financial results.
• Cue Health Inc. (NASDAQ:HLTH) shares fell 16.6% to $0.2669 in pre-market trading. Cue Health has received a decision to grant European patent number EP3191849 titled "Systems and Methods for Detection and Quantification of Analytes."
• B. Riley Financial, Inc. (NASDAQ:RILY) shares declined 14.5% to $15.67 in pre-market trading after the company reported fourth-quarter financial results and announced it has launched a review of strategic alternatives for its Appraisal and Valuation Services, and Retail, Wholesale & Industrial Solutions businesses.

Now Read This: Dell, SoundHound AI And 3 Stocks To Watch Heading Into Friday